Exploring technology agglomeration patterns for multinational pharmaceutical and biotechnology firms

By Ahn Mark J   Meeks Michael   Davenport Sally   Bednarek Rebecca  

Journal of Commercial Biotechnology, Vol. 16, Iss. 1, 2010-01 ,pp. : 17-32

Palgrave Macmillan Ltd

Access to resources Recommend Favorite

Using intellectual property to map the organisational evolution of firms: Tracing a biotechnology company from startup to bureaucracy to a multidivisional firm

By Daizadeh Iraj  

Journal of Commercial Biotechnology, Vol. 13, Iss. 1, 2006-10 ,pp. : 28-36

Palgrave Macmillan Ltd

Access to resources Recommend Favorite

Venture capital and the European biotechnology industry

By Lerer Leonard  

Journal of Commercial Biotechnology, Vol. 15, Iss. 3, 2009-07 ,pp. : 283-284

Palgrave Macmillan Ltd

Access to resources Recommend Favorite

Positioning strategies and prospects for success of emerging high-technology firms: the case of US biotechnology

By Vila Joaquim  

International Journal of Biotechnology, Vol. 3, Iss. 1-2, 2003-07 ,pp. : 57-81

Inderscience Publishers

Access to resources Recommend Favorite

Canadian biotech firms' creative capacity: on the role of absorptive capacity, relational capital, learning, and firm characteristics

By Traore Namatie  

International Journal of Biotechnology, Vol. 6, Iss. 1, 2004-05 ,pp. : 1-19

Inderscience Publishers

Access to resources Recommend Favorite